CD8A and neoplasm: Lastly, in a model of PDAC, residual macrophages remaining following targeted CSF-1/CSF-1R depletion strategies displayed increased expression of anti-tumor immunity genes, reduced expression of immunosuppressive molecules, and enhanced antigen presentation capabilities, thus, contributing to improved CD8+ T cell responses directing anti-tumor efficacy [161].